ARCHIVES

Weight An Indicator For Risk Of Developing Myeloma

This article is from The Cancer Letter archive.

Vol. 30 No. 8 | August 31, 2007

Download PDF Visit The Full Archive

Related Articles

5-FU/Levamisole A community Success Story; Trials With Untreated Control Revised Or Dropped

October 13, 1989

Natural Product Drug Discovery Groups Receive Concept Approval

February 26, 1988

September issue of Business & Regulatory Report included–8 additional pages of industry news.

October 1, 2004

Antigenics Begins Phase II Trial Of Oncophage for NHL.

March 31, 2000

Dana-Farber Correction Plan Sent To State; Pharmacy Chief Resigns

June 9, 1995

NCI Promises Strong Monitoring Process Visco Calls For Independent Review; Rep. Dingell Plans Hearing April 13

April 1, 1994